Advancements in haemophilia care have extended the life expectancy of persons with haemophilia (PWH), giving rise to new clinical challenges including the need for antithrombotic therapy (ATT) in mitigating...
Lire la suite

Haemophilia is a chronic bleeding disorder causing joint disease and pain, impacting quality of life (QoL) and function. Despite treatment advances, pain management remains challenging. This study uses...
Lire la suite

The Timed Up and Go (TUG) test is frequently used to assess patients' functional mobility. However, its psychometric characteristics in patients with haemophilia (PwH) are unknown. This study's primary...
Lire la suite

Bleeding disorders, including hemophilia, von Willebrand disease (VWD), and immune thrombocytopenia (ITP), pose significant diagnostic and therapeutic challenges due to their heterogeneous presentations and complex underlying mechanisms. Traditional diagnostic methods rely on clinical assessments and laboratory tests, which can be time-consuming and prone to misdiagnosis, particularly in resource-limited settings. Artificial intelligence (AI) has...
Lire la suite